|
Dr. Acharya has over 30 years experience in the scientific and business aspects of the medical device field. His primary focus is in U.S. and International device laws, regulations and clinical trial strategies. Dr. Acharya has previously held numerous senior-level positions over a 16-year period beginning in 1977 at the U.S. Food and Drug Administration, including Director of the Division of Cardiovascular, Respiratory and Neurological Devices, where he directed the review and approval of PMA, IDE and 510(k) submissions during a period of rapid evolution for device technologies that included the Artificial Heart and Implantable Defibrillators, Rate-responsive Pacemakers, Aneurysm Implants, Laser Catheters, and Coronary Stents.
From 1994 until 1997, Dr. Acharya was also Vice President Regulatory Affairs, Quality Assurance and Clinical Research at Target Therapeutics, which developed, manufactured and marketed neurovascular devices prior to being acquired by Boston Scientific Corporation in 1997. As a member of the senior management team at Target, he was responsible for the design and development of product and business strategies for the company’s competitive advantage and rapid growth. Other former positions include senior assignments at EndoTex Interventional Systems, which is focused on developing a less invasive therapeutic solution to treating carotid artery disease, and the Biometric Research Institute, which offered development planning, clinical trials management, data management, and statistical analyses.
Dr. Acharya currently serves on the Boards of Directors of Neomend, Inc., which was founded to design, develop, manufacture, and market resorbable biomaterials and minimally invasive medical devices in the areas of wound and soft tissue repair, and InfraReDx, Inc., which is involved in developing catheter based photo-medical technologies to diagnose vulnerable plaques. In addition, he also currently sits on the Board of Directors at Regen Biologics, which develops and markets tissue-remodeling technologies for knee injury repair. Dr. Acharya previously served on the Board of Directors of Somnus, Inc., which designed, developed, manufactured, and marketed medical devices for the treatment of upper airway disorders prior to being acquired by Gyrus Group PLC in 2001.
Dr. Acharya holds a B. Tech. Degree in Metallurgical Engineering from the Indian Institute of Technology, Kharagpur, India, and an M.S. and Ph.D. in Biomaterials Engineering from Northwestern University in Chicago, Illinois. | 